The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 11105 malaria professionals are enjoying the free benefits of MalariaWorld today

artemisinin

Not Open Access |Effect of the Affordable Medicines Facility—malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data

December 3, 2012 - 15:12 -- NOT Open Access
Author(s): 
Sarah Tougher, Yazoume Ye, Kara Hanson, et al.
Reference: 
The Lancet, Volume 380, Issue 9857, 1–7 December 2012, Pages 1916-1926
MalariaWorld

We present findings on the effect of AMFm on QAACT price, availability, and market share, 6–15 months after the delivery of subsidised ACTs in Ghana, Kenya, Madagascar, Niger, Nigeria, Uganda, and Tanzania (including Zanzibar).

Country: 

Free Book for MalariaWorld Members!

November 27, 2012 - 21:45 -- Bart G.J. Knols

This week I was contacted by Dr. Dana Dalrymple with a very unusual offer. He wishes to provide all MalariaWorld subscribers free access to his book 'Artemisia annua, Artemisinin, ACTs & Malaria Control in Africa' published just seven months ago. This is truly remarkable and we highly appreciate this gesture!

In his email he said: "This will get it to the heart of the international malaria community and doubtless reach many who otherwise may not have heard of, or had access to, it." That is the spirit of truly open and global collaboration we aim to achieve with MalariaWorld. So a big 'Thank you' to Dr. Dalrymple! If you download it, why not send him a private message through the platform (available to subcribers) to let him know you appreciate his action...

ATP and luciferase assays to determine the rate of drug action in in vitro cultures of Plasmodium falciparum

November 12, 2012 - 09:40 -- Open Access
Author(s): 
Khan T, van Brummelen AC, Parkinson CJ, Hoppe HC
Reference: 
Malaria Journal 2012, 11:369 (7 November 2012)
MalariaWorld

ATP levels and luciferase activity respond rapidly to incubation with anti-malarial drugs and provide quantitative read-outs to detect the appearance and magnitude of drug-induced stress in cultured parasites.

Price Subsidy Schemes for Artemisinin-Based Combination Therapies (ACTs): Do They Work?

April 5, 2011 - 19:26 -- The Global Heal...

Although ACTs are recommended as first line treatment for uncomplicated malaria, actual use of ACT is very limited, partly due to its high price in pharmacies and retail stores. The Affordable Medicines Facility-malaria (AMFm), a donor-funded global price subsidy, has been proposed as a strategy to increase ACT use in malaria-endemic countries. Given that donor-supported ACT subsidy schemes are costly, it is crucial to ensure that they have their intended impact.

Pages

Subscribe to RSS - artemisinin